Logo image of MODV

MODIVCARE INC (MODV) Stock Fundamental Analysis

USA - NASDAQ:MODV - US60783X1046 - Common Stock

0.4319 USD
-0.15 (-25.23%)
Last: 8/27/2025, 8:05:27 PM
0.4569 USD
+0.02 (+5.79%)
After Hours: 8/27/2025, 8:05:27 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MODV. MODV was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of MODV have multiple concerns. MODV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year MODV has reported negative net income.
In the past year MODV has reported a negative cash flow from operations.
In the past 5 years MODV reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MODV reported negative operating cash flow in multiple years.
MODV Yearly Net Income VS EBIT VS OCF VS FCFMODV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

MODV's Return On Assets of -13.68% is on the low side compared to the rest of the industry. MODV is outperformed by 78.43% of its industry peers.
MODV has a Return On Invested Capital (0.67%) which is comparable to the rest of the industry.
MODV had an Average Return On Invested Capital over the past 3 years of 1.96%. This is significantly below the industry average of 9.33%.
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROIC 0.67%
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
MODV Yearly ROA, ROE, ROICMODV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

Looking at the Operating Margin, with a value of 0.42%, MODV is in line with its industry, outperforming 40.20% of the companies in the same industry.
MODV's Operating Margin has declined in the last couple of years.
The Gross Margin of MODV (15.15%) is worse than 63.73% of its industry peers.
MODV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.42%
PM (TTM) N/A
GM 15.15%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
MODV Yearly Profit, Operating, Gross MarginsMODV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MODV is destroying value.
Compared to 1 year ago, MODV has more shares outstanding
MODV has more shares outstanding than it did 5 years ago.
MODV has a worse debt/assets ratio than last year.
MODV Yearly Shares OutstandingMODV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MODV Yearly Total Debt VS Total AssetsMODV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MODV has an Altman-Z score of 1.34. This is a bad value and indicates that MODV is not financially healthy and even has some risk of bankruptcy.
MODV has a worse Altman-Z score (1.34) than 63.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.13
WACC5.2%
MODV Yearly LT Debt VS Equity VS FCFMODV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

MODV has a Current Ratio of 0.80. This is a bad value and indicates that MODV is not financially healthy enough and could expect problems in meeting its short term obligations.
MODV has a worse Current ratio (0.80) than 83.33% of its industry peers.
MODV has a Quick Ratio of 0.80. This is a bad value and indicates that MODV is not financially healthy enough and could expect problems in meeting its short term obligations.
MODV has a worse Quick ratio (0.80) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
MODV Yearly Current Assets VS Current LiabilitesMODV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

MODV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.76%.
MODV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.09% yearly.
The Revenue has decreased by -0.70% in the past year.
The Revenue has been growing by 13.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%

3.2 Future

The Earnings Per Share is expected to grow by 19.50% on average over the next years. This is quite good.
MODV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.26% yearly.
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MODV Yearly Revenue VS EstimatesMODV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
MODV Yearly EPS VS EstimatesMODV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MODV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MODV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MODV Price Earnings VS Forward Price EarningsMODV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MODV is valued cheaply inside the industry as 81.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.73
MODV Per share dataMODV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as MODV's earnings are expected to grow with 19.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-100.18%
EPS Next 3Y19.5%

0

5. Dividend

5.1 Amount

No dividends for MODV!.
Industry RankSector Rank
Dividend Yield N/A

MODIVCARE INC

NASDAQ:MODV (8/27/2025, 8:05:27 PM)

After market: 0.4569 +0.02 (+5.79%)

0.4319

-0.15 (-25.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners97.01%
Inst Owner Change-0.01%
Ins Owners0.87%
Ins Owner Change-0.02%
Market Cap6.20M
Analysts43.33
Price Target2.01 (365.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-114.73%
Min EPS beat(2)-235.29%
Max EPS beat(2)5.84%
EPS beat(4)1
Avg EPS beat(4)-94.09%
Min EPS beat(4)-235.29%
Max EPS beat(4)5.84%
EPS beat(8)2
Avg EPS beat(8)-63.41%
EPS beat(12)4
Avg EPS beat(12)-37.21%
EPS beat(16)8
Avg EPS beat(16)-21.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-1.23%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-3.73%
Max Revenue beat(4)-1.23%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.97%
Revenue beat(16)7
Avg Revenue beat(16)0.31%
PT rev (1m)0%
PT rev (3m)-66.74%
EPS NQ rev (1m)41.67%
EPS NQ rev (3m)-887.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.47%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.73
EPS(TTM)-1.1
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-8.49
FCFYN/A
OCF(TTM)-6.83
OCFYN/A
SpS191.9
BVpS-6.11
TBVpS-72.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROCE 1.14%
ROIC 0.67%
ROICexc 0.73%
ROICexgc 3.11%
OM 0.42%
PM (TTM) N/A
GM 15.15%
FCFM N/A
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
ROICexc(3y)2.01%
ROICexc(5y)4.28%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.56%
ROCE(5y)4.87%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-39.44%
ROICexc growth 5Y-26.6%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
F-Score3
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.6
Cap/Depr 22.51%
Cap/Sales 0.87%
Interest Coverage 0.11
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 1.34
F-Score3
WACC5.2%
ROIC/WACC0.13
Cap/Depr(3y)32.88%
Cap/Depr(5y)36.51%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A
EBIT growth 1Y-59.03%
EBIT growth 3Y-46.99%
EBIT growth 5Y-12.71%
EBIT Next Year217.45%
EBIT Next 3Y52.19%
EBIT Next 5YN/A
FCF growth 1Y0.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.91%
OCF growth 3YN/A
OCF growth 5YN/A